` DXCM (Dexcom Inc) vs S&P 500 Comparison - Alpha Spread

DXCM
vs
S&P 500

Over the past 12 months, DXCM has underperformed S&P 500, delivering a return of -31% compared to the S&P 500's 9% growth.

Stocks Performance
DXCM vs S&P 500

Loading
DXCM
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
DXCM vs S&P 500

Loading
DXCM
S&P 500
Difference
www.alphaspread.com

Performance By Year
DXCM vs S&P 500

Loading
DXCM
S&P 500
Add Stock

Competitors Performance
Dexcom Inc vs Peers

Dexcom Inc
Glance View

Economic Moat
Narrow
Market Cap
31.8B USD
Industry
Health Care

Dexcom Inc. emerged as a pioneering force in the realm of continuous glucose monitoring (CGM), redefining the landscape of diabetes management. Founded in 1999, this San Diego-based company disrupted traditional blood glucose monitoring with its innovative technology, allowing individuals to track glucose levels in real-time without frequent finger-pricking. The company’s CGM systems, such as the G6 model, utilize a small sensor inserted beneath the skin that transmits data to a wearable device or smartphone, allowing patients and healthcare providers a comprehensive view of glucose trends. This approach empowers users with critical information for better diabetes management, reducing the likelihood of complications resulting from high or low blood sugar. Dexcom’s revenue generation revolves around the sales of its CGM systems, sensors, and related software services. By selling the initial monitoring devices and disposable sensors that typically need to be replaced every ten days, the company ensures a steady, recurring revenue stream. Furthermore, its integration with healthcare providers and insurers broadens its reach, tapping into a vast network of patients worldwide. Dexcom also collaborates with tech giants to enhance interoperability and data analytics, thereby embedding its solutions in broader digital health ecosystems. As diabetes continues to be a growing global concern, Dexcom’s strategic focus on innovation and strategic partnerships positions it as a leader in the CGM market.

DXCM Intrinsic Value
50.47 USD
Overvaluation 38%
Intrinsic Value
Price
Back to Top